HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UFC Fighter Hits Genkor Tribulus Supplement With SARMs Complaint

This article was originally published in The Rose Sheet

Executive Summary

Former UFC heavyweight champ Joshua Barnett's lawsuit filed in California state court two weeks after his suspension from UFC bouts was lifted alleges that BioKor’s Genkor Tributestin 750 supplement he used contained an undeclared ingredient, ostarine, a selective androgen receptor modulator that is a "dangerous chemical that is not approved for human consumption under any circumstances."

You may also be interested in...

Split Decision In UFC Athlete's Complaint About Steroid-Containing Supplements

Some clams in Ultimate Fighting Championship competitor Lyman Good's complaint against Vitamin Shoppe, Gaspari Nutrition, Hi-Tech Pharmaceuticals and Millennium Sport Technologies will stand. Good's counsel, however, made "threadbare" arguments to sustain other charges he alleged, a judge says in New York federal court.

SARMs Supplement Researchers Call For Online Sales Crackdown

A JAMA study finds SARMs in 23 of 44 products marketed online as containing the steroid-like ingredient while the rest contained other unapproved drugs and substances. Sports medicine and doping researchers say e-commerce provides cover for firms to sell the risky bodybuilding drugs without consequence.

SARMs Spells Latest 'Synthetic Steroids' FDA Finds In Supplements

FDA warns three US firms marketing products labeled as dietary supplements but containing selective androgen receptor modulators, SARMs, anabolic steroid-like ingredients that have the potential to increase the risk of heart attack and stroke and for which long-term effects are unknown.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts